Chemical Compound

GSK-A1|1416334-69-4|5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|PI4KA inhibitor-A1|A1

CAS Registry Number 1416334-69-4
返回搜索 申请报价
GSK-A1|1416334-69-4|5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|PI4KA inhibitor-A1|A1 结构式
Primary record

GSK-A1|1416334-69-4|5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|PI4KA inhibitor-A1|A1

库存
2,216 克
纯度
98.2 %
CAS
1416334-69-4

化合物标识与属性

CAS
1416334-69-4
PubChem CID
71116366
SMILES
COC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(N3C4=CC=C(C=C4)N5CCOCC5)N)S(=O)(=O)NC6=CC=CC=C6F
Canonical SMILES
COc1ncc(-c2ccc3nc(N)n(-c4ccc(N5CCOCC5)cc4)c3c2)cc1S(=O)(=O)Nc1ccccc1F

名称与同义词

  • GSK-A1
  • PI4KA inhibitor-A1
  • 1416334-69-4
  • PI4KA inhibitor-A1?
  • A1;GSKA1
  • C29H27FN6O4S
  • orb1305074
  • SCHEMBL14247403
  • SCHEMBL29923006
  • SCHEMBL30089076
  • SYN1219
  • MFCD29770784
  • GLXC-07611
  • BCP28055
  • EX-A5297
  • RGC33469
  • AKOS037643421
  • ZINC144874408
  • AC-36732
  • AS-16345
  • SY491824
  • HY-125118
  • CS-0089366
  • G62134
  • A900427
  • 5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-(2-Amino-1-(4-morpholinophenyl)-1H-benzimidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-(2-amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-[2-Amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide
  • 5-[2-AMINO-1-[4-(MORPHOLIN-4-YL)PHENYL]-1H-1,3-BENZODIAZOL-6-YL]-N-(2-FLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE
  • 5-[2-amino-3-(4-morpholinophenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxy-pyridine-3-sulfonamide
  • 5-{2-AMINO-3-[4-(MORPHOLIN-4-YL)PHENYL]-1,3-BENZODIAZOL-5-YL}-N-(2-FLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE
  • E4S
  • GSK-A1|1416334-69-4|5-[2-amino-3-(4-morpholin-4-ylphenyl)benzimidazol-5-yl]-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|5-{2-amino-1-[4-(morpholin-4-yl)phenyl]-1H-benzimidazol-6-yl}-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide|PI4KA inhibitor-A1|A1